In today’s episode, a short episode for this week with only one new product approval. We will be discussing the approval of Abecma, a new CAR-T therapy for multiple myeloma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode the new product we’ll be discussing is Zegalogue for the treatment of episodes of hypoglycemia. We also have two products with new indications - Arcalyst for pericarditis, and Myrbetriq for neurogenic detrusor overactivity. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we'll be discussing the approval of Ponvory, for multiple sclerosis and Kimyrsa, a new antibiotic for skin and soft tissue infections including MRSA. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes we'll be discussing the approval of Azstarys for ADHD and approval of Fotivda as 3rd line treatment for renal cell carcinoma. We’ll also be discussing an added indication for Yescarta for 3rd line treatment in follicular lymphoma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes we'll be discussing the big news from this week, that’s the EUA just issued for Janssen’s COVID vaccine. We’ll also be discussing two new drug approvals - Nulibry for a rare genetic disorder, and Pepaxto for multiple myeloma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes we'll be discussing the approval of UKONIQ for specific types of non-Hodgkin lymphoma and approval of Evkeeza as add on therapy in treating LDL/bad cholesterol. We'll also be discussing the approval of Cosela given before chemotherapy to reduce the risk of bone marrow suppression. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes we'll be discussing the approval of Verquvo for the treatment of heart failure and approval of Tepmetko, a new treatment for metastatic non small cell lung cancer with MET alternations. We'll also be discussing the approval of a new combination therapy for renal cell carcinoma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we'll be discussing the approval of Gemtesa for overactive bladder, and approval of an added indication of Enhertu for HER2 positive gastric cancer. We'll also go through the approval of a new monthly injectable product for HIV treatment. Don't forget to like, share, and subscribe! Enjoy!

In today’s episode well be discussing the approval of Margenza as part of a combination treatment regimen for HER2 positive breast cancer, and the approval of Orgovyx for the treatment of advanced prostate cancer. The more important news is the issuance of an EUA for the second COVID vaccine - this time from Moderna. Don't forget to like, share, and subscribe! Enjoy!

For today's episodes i’m going to focus on the FDA emergency use authorization for the Pfizer COVID19 vaccine that was approved, but there are other approvals from this week including Danyelza and Orladeyo; i’ll put links below to get to the articles about them. Don't forget to like, share, and subscribe! Enjoy!